"Your Premier Strategic & Regulatory Partner for Life Sciences in Europe."
"Navigating complex European regulations to accelerate global bio-innovations,
from breakthrough therapies to advanced medical aesthetics."
Pharma & Biotech Division
Innovative Therapies & Clinical Solutions
Strategic consulting for breakthrough drugs and innovative therapies (médicaments et thérapies innovantes).
Clinical trial management and European regulatory submission support.
Strategic Structuring of Clinical Programs & Exclusive EU R&D Financing.
Medical Devices & Aesthetics Division
CE MDR Compliance & Market Gateway
European Authorized Representative (EC Rep) Services: Serving as your official, legally compliant entity within the European Union.
PRRC (Person Responsible for Regulatory Compliance) Solutions: Led by qualified expert to guarantee strict adherence to EU MDR/IVDR requirements.
KOL Advisory Boards: Orchestrating authoritative clinical validation and curating exclusive KOL advisory boards to elevate premium K-aesthetics within the European landscape.
"In strategic alliance with South Korea’s top-tier Clinical Research Organizations (CROs), HERON serves as the exclusive gateway bridging K-Bio innovations and the European market."
HERON in the Media
Orchestrating Early Clinical Success via FDA/EMA Expedited Programs: Fast Track, Breakthrough & PRIME Designations
Highlighted by Medipana News following an exclusive symposium presentation, HERON unveiled strategic blueprints for leveraging expedited regulatory pathways. As the premier clinical regulatory architect, we empower South Korean innovative new drug developers to optimize early-stage clinical development and secure Fast Track, Breakthrough, and PRIME designations for rapid global clinical development implementation.